Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
44.63
-0.98 (-2.15%)
At close: Jul 31, 2026, 4:00 PM EDT
45.01
+0.38 (0.85%)
After-hours: Jul 31, 2026, 7:45 PM EDT
Supernus Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $66 | Buy | Reiterates | $66 | +47.88% | Jul 27, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $63 | Buy | Maintains | $63 | +41.16% | Jul 13, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $65 | Buy | Maintains | $65 | +45.64% | Jul 10, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $63 → $67 | Buy | Maintains | $63 → $67 | +50.12% | Jul 9, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $55 | Hold | Maintains | $55 | +23.24% | May 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $65 | Buy | Maintains | $65 | +45.64% | May 6, 2026 |